Emboline Inc

SANTA CRUZ, CA · Medtech · Private

Total-body embolic protection system that captures debris during transcatheter procedures

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · emboline.com

Sector
Medtech
Headquarters
SANTA CRUZ, CA
Latest Form D
$55.4M, Jun 2021
Total capital
$64.9M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$64.9M
2 Form D · last Jun 2021
65 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
26
14 pending · first 2014
Rank in peer group#87 of 1112

Capital timeline

20202021FEDERAL ↑EQUITY ↓Cumulative $64.9M1st Form D$9.5M2nd Form D$55.4M
20202021FEDERAL ↑EQUITY ↓Cumulative $64.9M1st Form D$9.5M2nd Form D$55.4M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$55.4M
  • Private capital raisedForm D · SEC · 1st filing$9.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#87 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Scott RussellResearcherExecutive Officer, DirectorLinked by 1 patent
  • Amir BelsonExecutive Officer, DirectorNamed in SEC Form D filings
  • Elton SatuskyExecutive OfficerNamed in SEC Form D filings
  • Eric XiaoDirectorNamed in SEC Form D filings
  • Issam D. MoussaDirectorNamed in SEC Form D filings
  • J. Casey D. McGlynnExecutive OfficerNamed in SEC Form D filings
Show all 9 people
  • Nicholas PappasDirectorNamed in SEC Form D filings
  • Peng ChengDirectorNamed in SEC Form D filings
  • William DaiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 26 granted of 40
Show all 40 patent records
  • ELORAC, INC.Similar federal contract value in Medtech · null in contracts
  • CELESTIAL ONCOLOGY INC.Similar federal contract value in Medtech · null in contracts
  • POLAREAN, INC.Similar federal contract value in Medtech · null in contracts
  • Endeavor Orthopaedics, Inc.Similar federal contract value in Medtech · null in contracts
  • Momentum Women LLCSimilar federal contract value in Medtech · null in contracts
  • SAVICELL CorpSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .